BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can be targeted, the system can be vulnerable to attacks such as system fingerprinting, internal port scanning, Server Side Request Forgery (SSRF), or remote code execution (RCE).
CVE-2017-17674
This critical-severity CVE scores 9.8 under NVD CVSS v3. EPSS exploit probability: 3.3%, top 13% of all CVEs by exploit prediction. GitHub Security Advisory data not yet ingested — confidence will rise once GHSA publishes (typical lag: hours to days for open-source ecosystem CVEs; never for infrastructure-only CVEs).
- High severity, but no confirmed exploitation yet
No vendor fix yet — apply a workaround or compensating control (WAF / firewall / segmentation) and watch for a patch.
- CVSS v3
- 9.8
- EG Score
- 9.8(medium)
- EPSS
- 79.2%
- KEV
- Not listed
Published
May 19, 2021
Last Modified
July 9, 2026
Advisory Details (2)
Auto-updated Jul 9, 2026Full Disclosure: Multiple vulnerabilities in BMC Remedy
https://seclists.org/fulldisclosure/2017/Oct/52Vendor Advisories for CVE-2017-17674(1)
These vendors published their own advisory mentioning this CVE — often with vendor-specific remediation steps + affected product lists not in NVD.
Weakness Classification(1)
MITRE Common Weakness Enumeration — the root-cause categories this CVE belongs to.
Frequently asked(5)
What is CVE-2017-17674?
When was CVE-2017-17674 disclosed?
Is CVE-2017-17674 actively exploited?
What is the CVSS score of CVE-2017-17674?
How do I remediate CVE-2017-17674?
Dependency Blast Radius
Explore the affected products and dependency analysis for CVE-2017-17674
Is Your Infrastructure Affected by CVE-2017-17674?
EchelonGraph automatically scans your cloud infrastructure and maps CVE exposure using blast radius analysis.